Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
Home>Topics>>An Australian judge has approved a settlement between J&J (JNJ) and patients who received dodgy knee implants, clearing the way for the company to pay compensation of at least A$30,000 ($31,000) per ...

An Australian judge has approved a settlement between J&J (JNJ) and patients who received dodgy knee implants, clearing the way for the company to pay compensation of at least A$30,000 ($31,000) per ...

SeekingAlpha.com: SA Currents

Tue, 4 Dec 2012

An Australian judge has approved a settlement between J&J ( JNJ ) and patients who received dodgy knee implants, clearing the way for the company to  pay compensation of at least A$30,000 ($31,000) per case. J&J recalled the implant in 2009 following reports of defects. Over 5,070 implants were ...

Read the rest of this article on SeekingAlpha.com: SA Currents

Related Videos

  1. Why J&J Bought a Big Piece of Elan

    Fri, 4 Dec 2009

    Morningstar's Damien Conover and Alex Morozov discuss what J&J's stake in biotech Elan means for both companies.

Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.